Further observations in congenital myasthenic syndromes

Annals of the New York Academy of Sciences

Volumn 1132, Issue , 2008, Pages 104-113

  Engel, Andrew G ^a,c   Shen, Xin Ming ^a   Selcen, Duygu ^a   Sine, Steven M ^b  

^a Mayo Clinic   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Acetylcholine receptor; Acetylcholinesterase; Choline acetyltransferase; Congenital myasthenic syndromes; Dok 7

Indexed keywords

CHOLINE ACETYLTRANSFERASE; CHOLINERGIC RECEPTOR; EPHEDRINE;

CLINICAL FEATURE; CONFERENCE PAPER; CONGENITAL MYASTHENIC SYNDROME; GENE EXPRESSION; GENE MUTATION; GENE STRUCTURE; GENE TARGETING; GENETIC DISORDER; GENOTYPE; HUMAN; PHENOTYPE;

EID: 45249107304     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1405.039     Document Type: Conference Paper

References (27)

1. Ohno, K., A. Tsujino, J.M. Brengman, et al. 2001. Choline acetyltransferase mutations cause myasthenic syndrome associated with episodic apnea in humans. Proc. Natl. Acad. Sci. USA 98 : 2017 2022.
2. Kimbell, L.M., K. Ohno, A.G. Engel, et al. 2004. C-terminal and heparin-binding domains of collagenic tail subunit are both essential for anchoring acetylcholinesterase at the synapse. J. Biol. Chem. 279 : 10997 11005.
3. Deprez, P.N. & N.C. Inestrosa. 1995. Two heparin-binding domains are present on the collagenic tail of asymmetric acetylcholinesterase. J. Biol. Chem. 270 : 11043 11046.
4. Bestue-Cardiel, M., A.S. de-Cabazon-Alvarez, J.L. Capablo-Liesa, et al. 2005. Congenital endplate acetylcholinesterase deficiency responsive to ephedrine. Neurology 65 : 144 146.
5. Brengman, J.M., J.L. Capablo-Liesa, J. Lopez-Pison, et al. 2006. Ephedrine treatment of seven patients with congenital endplate acetylcholinesterase deficiency. Neuromuscul. Disord. 16 (Suppl 1 S129.
6. Shen, X.-M., K. Ohno, A. Tsujino, et al. 2003. Mutation causing severe myasthenia reveals functional asymmetry of AChR signature Cys-loops in agonist binding and gating. J. Clin. Invest. 111 : 497 505.
7. Shen, X.-M., K. Ohno, S.M. Sine, et al. 2005. Subunit-specific contribution to agonist binding and channel gating revealed by inherited mutation in muscle AChR M3-M4 linker. Brain 128 : 345 355.
8. Shen, X.-M., T. Fukuda, K. Ohno, S.M. Sine & A.G. Engel. 2008. Novel AChR δ subunit mutation causes myasthenia by interfering with inter-subunit communication essential for channel gating. J. Clin. Invest. 118 : 1867 1876.
9. Mukhtasimova, N. & S.M. Sine. 2007. An inter-subunit trigger of channel gating in the muscle nicotinic receptor. J. Neurol. Sci. 27 : 4110 4119.
10. Horovitz, A. & A. Fersht. 1990. Strategy for analyzing the co-operativity of intramolecular interactions in peptides and proteins. J. Mol. Biol. 214 : 613 617.
11. Fukudome, T., K. Ohno, J.M. Brengman, et al. 1998. Quinidine normalizes the open duration of slow-channel mutants of the acetylcholine receptor. Neuroreport 9 : 1907 1911.
12. Harper, C.M. & A.G. Engel. 1998. Safety and efficacy of quinidine sulfate in slow-channel congenital myasthenic syndrome. Ann. N.Y. Acad. Sci. 841 : 203 206.
13. Harper, C.M., T. Fukudome & A.G. Engel. 2003. Treatment of slow channel congenital myasthenic syndrome with fluoxetine. Neurology 60 : 170 173.
14. Elbashir, S.M., J. Harborth, W. Lendeckel, et al. 2001. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411 : 494 498.
15. Brummelkamp, T.R., R. Bernards & R. Agami. 2002. A system for stable expression of short interfering RNAs in mammalian cells. Science. 296 : 550 553.
16. Paddison, P.J., A.A. Caudy & G.J. Hannon. 2002. Stable suppression of gene expression by RNAi in mammalian cells. Proc. Natl. Acad. Sci. USA 99 : 1443 1448.
17. Abdelgany, A., M. Wood & D. Beeson. 2003. Allele-specific silencing of a pathogenic mutant acetylcholine receptor subunit by RNA interference. Hum. Mol. Genet. 12 : 2637 2644.
18. Kapadia, S.B., A. Brideau-Andersen & F.V. Chisari. 2003. Interference of hepatitis C virus RNA replication by short interfering RNAs. Proc. Natl. Acad. Sci. USA 100 : 2014 2018.
19. McManus, M.T. & P.A. Sharp. 2002. Gene silencing in mammals by small interfering RNAs. Nat. Rev. Genet. 3 : 737 747.
20. Shen, X.-M., F. Deymeer, S.M. Sine, et al. 2006. Slow-channel mutation in AChR αM4 domain and its efficient knockdown. Ann. Neurol. 60 : 128 136.
21. Kumar, R., D.S. Conklin & V. Mittal. 2003. High-throughput selection of effective RNAi probes for gene silencing. Genome Res. 13 : 2333 2340.
22. Okada, K., A. Inoue, M. Okada, et al. 2006. The muscle protein Dok-7 is essential for neuromuscular synaptogenesis. Science 312 : 1802 1805.
23. Beeson, D., O. Higuchi, J. Palace, et al. 2006. Dok-7 mutations underlie a neuromuscular junction synaptopathy. Science 313 : 1975 1978.
24. Slater, C.R., P.R. W. Fawcett, T.J. Walls, et al. 2006. Pre- and postsynaptic abnormalities associated with impaired neuromuscular transmission in a group of patients with 'limb-girdle myasthenia'. Brain 127 : 2061 2076.
25. Selcen, D., M. Milone, X.-M. Shen, et al. 2007. Dok-7 myasthenia: clinical spectrum, endplate electrophysiology and morphology, 12 novel DNA rearrangements, and genotype-phenotype relations in a Mayo cohort of 13 patients [abstract]. Neurology 68 (Suppl 1 A106 A107.
26. Engel, A.G., K. Ohno & S.M. Sine. 2004. Congenital myasthenic syndromes. In Myology, 3rd ed. A.G. Engel & C. Franzini-Armstrong, Eds 1755 1790. McGraw-Hill. New York.
27. Unwin, N. 2005. Refined structure of the nicotinic acetylcholine receptor at 4 Å resolution. J. Mol. Biol. 346 : 967 989.